Peric-Golia L, Gardner C F, Peric-Golia M
Endocr Res Commun. 1982;9(3-4):179-84. doi: 10.3109/07435808209045763.
In order to investigate the source of the additional circulating cholesterol in hypercholesterolemia induced by neurotensin (NT), 12.5 pmol/100 g body weight NT was injected into the tail veins of rats which received by the same route 1 X 10(6) dpm/100 g body weight cholesterol-4-14C 24 hours earlier. Fifteen minutes later the concentration of the labeled plasma cholesterol was the same in the treated animals and in the controls. However, specific activity of plasma cholesterol significantly decreased in rats that received NT, while it remained unchanged in the controls. These data suggest that the additional circulating cholesterol after the intravenous administration of NT was either newly formed or originated in some tissue where equilibrium between endogenous and exogenous cholesterol has not yet been established.
为了研究神经降压素(NT)诱导的高胆固醇血症中额外循环胆固醇的来源,将12.5 pmol/100 g体重的NT注入大鼠尾静脉,这些大鼠在24小时前已通过相同途径接受了1×10(6) dpm/100 g体重的胆固醇-4-14C。15分钟后,处理组动物和对照组动物血浆中标记胆固醇的浓度相同。然而,接受NT的大鼠血浆胆固醇的比活性显著降低,而对照组则保持不变。这些数据表明,静脉注射NT后额外循环的胆固醇要么是新形成的,要么源自某些尚未建立内源性和外源性胆固醇平衡的组织。